Recovery of pituitary function after treatment with a targeted cytotoxic analog of luteinizing hormone-releasing hormone.
about
A phenotypic high throughput screening assay for the identification of pharmacoperones for the gonadotropin releasing hormone receptor[DLys(6)]-luteinizing hormone releasing hormone-curcumin conjugate inhibits pancreatic cancer cell growth in vitro and in vivo.Chaperoning G protein-coupled receptors: from cell biology to therapeuticsReceptor-targeting phthalocyanine photosensitizer for improving antitumor photocytotoxicity.Selective induction of apoptosis by the cytotoxic analog AN-207 in cells expressing recombinant receptor for luteinizing hormone-releasing hormone.Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: implications for the design of preclinical studies.Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.Targeting of cytotoxic luteinizing hormone-releasing hormone analogs to breast, ovarian, endometrial, and prostate cancers.Receptor-mediated tumor targeting based on peptide hormones.Luteinizing hormone-releasing hormone receptor targeted agents for prostate cancer.Gonadotropin-releasing hormone targeting for gonadotroph ablation: an approach to non-surgical sterilization.Administration of a targeted cytotoxic analog of luteinizing hormone-releasing hormone inhibits growth of estrogen-independent MDA-MB-231 human breast cancers in nude mice.Effect of nano-zinc oxide on doxorubicin- induced oxidative stress and sperm disorders in adult male Wistar rats.Lamprey gonadotropin hormone-releasing hormone-III has no selective follicle-stimulating hormone-releasing effect in rats.Targeted cytotoxic analogue of luteinizing hormone-releasing hormone (LH-RH) only transiently decreases the gene expression of pituitary receptors for LH-RH.
P2860
Q33629937-1BAA1919-4B74-4A63-9A51-20641C4829C4Q33724860-290235F7-F1EF-47B0-AFD8-018FEB285623Q33927508-6F44A68E-CBE9-4823-A12E-292263CB6E20Q34302297-74EA0A31-A3E5-4DC3-A3AA-D03FF6CF86BBQ34840155-06A790D0-4F89-4029-9C31-172CD342F278Q34979199-AA40EA25-D822-411A-86D6-4AF7F677626FQ35891113-70989DAA-CD62-45AB-8896-2C0053F1DF78Q36202016-D3B97F54-7DBA-44D2-AC0F-22429FB9D54CQ37641368-BE135930-2FFE-4912-95D8-8007F87ADA76Q37859389-5754A11B-0C12-470A-B67F-6F37E1AE61A5Q38029046-48C0871E-402B-4310-88E7-2A19670C35EBQ38311828-6FBCD85B-E0C7-43E1-958A-4DB72DEC0504Q41995543-278D24BD-F753-448E-BD25-B51ED3CFD29DQ48524540-969354D8-5760-4443-B207-ABDC288582CFQ48656281-FAD07513-8F6F-458B-8B63-B1D4BA2D629F
P2860
Recovery of pituitary function after treatment with a targeted cytotoxic analog of luteinizing hormone-releasing hormone.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Recovery of pituitary function ...... ing hormone-releasing hormone.
@ast
Recovery of pituitary function ...... ing hormone-releasing hormone.
@en
type
label
Recovery of pituitary function ...... ing hormone-releasing hormone.
@ast
Recovery of pituitary function ...... ing hormone-releasing hormone.
@en
prefLabel
Recovery of pituitary function ...... ing hormone-releasing hormone.
@ast
Recovery of pituitary function ...... ing hormone-releasing hormone.
@en
P2093
P2860
P356
P1476
Recovery of pituitary function ...... zing hormone-releasing hormone
@en
P2093
P2860
P304
P356
10.1073/PNAS.94.4.1420
P407
P577
1997-02-01T00:00:00Z